Form 4: Carmell Corp Director Patrick Sturgeon Increases Stake in Company

Director Patrick Sturgeon reports acquiring additional shares of Carmell Corp through direct purchases and participation in Carmell Insiders LLC.

Summary

• Patrick Sturgeon, a director of Carmell Corp, reported changes in his beneficial ownership of the company's common stock.
• On August 28, 2024, he acquired 970 shares at $0.56 per share through Carmell Insiders LLC.
• On August 29, 2024, he acquired 652 shares at $0.56 per share through Carmell Insiders LLC.
• He also directly owns 19,220 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of the filing date.
• Additionally, he directly owns 97,038 shares of common stock, 50% of which are subject to forfeiture if the stock price doesn't reach $11.50 for 20 trading days within a 30-day period in the five years after July 14, 2023.
• As of the report, Sturgeon indirectly owns 16,681 shares through Carmell Insiders LLC.
• The total amount invested in the LLC by its members was $130,750 as of the date of this filing.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The director's increased stake suggests confidence, but the forfeiture clause introduces a degree of uncertainty.

Positives

• A director increasing their stake in the company can be seen as a positive signal, indicating confidence in the company's future prospects.

Risks

• 50% of the directly owned shares are subject to forfeiture if the stock price does not reach $11.50 within five years, indicating a potential risk if the company's performance does not meet expectations.

Industry Context

This filing reflects routine insider trading activity, which is common in publicly traded companies. Monitoring such filings helps investors understand management's sentiment and confidence in the company.

Comparison to Industry Standards

• Insider trading is a common practice, and the legality of these transactions depends on compliance with regulations like Rule 10b5-1, which allows insiders to trade under pre-arranged plans to avoid accusations of trading on material non-public information.
• Comparable companies in the biotech or medical device space often have similar insider trading activities, with directors and officers periodically adjusting their holdings based on personal financial planning and company performance.

Stakeholder Impact

• The increased stake by a director could positively influence shareholder confidence.
• Employees may view this as a positive sign of leadership's commitment.

Key Dates

Keywords

Carmell Corp, CTCX, Patrick Sturgeon, Insider Trading, Beneficial Ownership, Stock Options, Common Stock, Director